Extreme heat exposure around diagnosis is linked to higher mortality in multiple myeloma
Dr Thomas Kuczmarski speaks to ecancer about climate and environmental factors drive seasonal risk of invasive mucormycosis in haematologic malignancies.
He says that in an 11-year single-center analysis of patients with acute leukaemia and myelodysplastic syndrome, invasive mucormycosis incidence showed strong seasonal and environmental associations.
Higher ambient temperatures, along with lower precipitation and humidity, were significantly linked to increased infection rates, with the highest incidence observed during summer months.
These findings highlight the growing influence of climate-related environmental conditions on invasive fungal infections and suggest that real-time environmental data may help inform antifungal prevention strategies in vulnerable haematologic cancer populations as climate change accelerates.
Extreme heat exposure around diagnosis is linked to higher mortality in multiple myeloma
MS-553 shows promise in treating chronic lymphocytic leukaemia
TKI chemotherapy and ponatinib improve survival outcomes in blast phase CML
Consolidation treatment delays do not compromise survival in MRD-negative adult ALL
Black patients show inferior survival despite similar cytogenetics and treatment response
Asciminib shows high molecular response, favourable safety in 2L CML-CP
Rocbrutinib shows strong responses in resistant CLL, including BTKi- and venetoclax-exposed patients
Non-covalent BTK inhibitor pirtobrutinib shows promise as frontline therapy for CLL/SLL
Linvoseltamab monotherapy in newly diagnosed multiple myeloma shows impressive frontline responses